Search research articles
Contact Us
Filters
Showing results (131-140 of 151) with videos related to
Page
of 16
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 24, 1999
Comparison of high-dose therapy and autologous stem-cell transplantation with conventional therapy for Hodgkin's disease induction failure: a case-control study. Société Francaise de Greffe de Moelle
M André, M Henry-Amar, J L Pico, et al.
Leukemia
|
July 11, 2008
The expression of 16 genes related to the cell of origin and immune response predicts survival in elderly patients with diffuse large B-cell lymphoma treated with CHOP and rituximab
J-P Jais, C Haioun, T J Molina, et al.
Leukemia & Lymphoma
|
March 28, 1998
PreB1 (CD10-) acute lymphoblastic leukemia: immunophenotypic and genomic characteristics, clinical features and outcome in 38 adults and 26 children. The Groupe dEtude Immunologique des Leucémies
B Lenormand, M C Béné, J F Lesesve, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 28, 2023
Metabolic tumor volume predicts outcome in patients with advanced stage follicular lymphoma from the RELEVANCE trial
A S Cottereau, L Rebaud, J Trotman, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 14, 2018
Progression-free survival at 24 months (PFS24) and subsequent outcome for patients with diffuse large B-cell lymphoma (DLBCL) enrolled on randomized clinical trials
M J Maurer, T M Habermann, Q Shi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 21, 2016
Prognostic value of baseline total metabolic tumor volume (TMTV0) measured on FDG-PET/CT in patients with peripheral T-cell lymphoma (PTCL)
A S Cottereau, S Becker, F Broussais, et al.
Leukemia
|
July 20, 2007
Long-term follow-up of high-dose treatment with autologous haematopoietic progenitor cell support in 693 patients with follicular lymphoma: an EBMT registry study
S Montoto, C Canals, A Z S Rohatiner, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 14, 2012
Phase III study of ACVBP versus ACVBP plus rituximab for patients with localized low-risk diffuse large B-cell lymphoma (LNH03-1B)
N Ketterer, B Coiffier, C Thieblemont, et al.
Leukemia
|
January 23, 2009
Recurrent genomic aberrations combined with deletions of various tumour suppressor genes may deregulate the G1/S transition in CD4+CD56+ haematodermic neoplasms and contribute to the aggressiveness of the disease
F Jardin, M Callanan, D Penther, et al.
Bone Marrow Transplantation
|
June 18, 2013
The outcome of reduced intensity allogeneic stem cell transplantation and autologous stem cell transplantation when performed as a first transplant strategy in relapsed follicular lymphoma: an analysis from the Lymphoma Working Party of the EBMT
S P Robinson, C Canals, J J Luang, et al.
Page
of 16
Search research articles
Search
Showing results (131-140 of 151) with videos related to
Sort By:
Page
of 16
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 24, 1999
Comparison of high-dose therapy and autologous stem-cell transplantation with conventional therapy for Hodgkin's disease induction failure: a case-control study. Société Francaise de Greffe de Moelle
M André, M Henry-Amar, J L Pico, et al.
Leukemia
|
July 11, 2008
The expression of 16 genes related to the cell of origin and immune response predicts survival in elderly patients with diffuse large B-cell lymphoma treated with CHOP and rituximab
J-P Jais, C Haioun, T J Molina, et al.
Leukemia & Lymphoma
|
March 28, 1998
PreB1 (CD10-) acute lymphoblastic leukemia: immunophenotypic and genomic characteristics, clinical features and outcome in 38 adults and 26 children. The Groupe dEtude Immunologique des Leucémies
B Lenormand, M C Béné, J F Lesesve, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 28, 2023
Metabolic tumor volume predicts outcome in patients with advanced stage follicular lymphoma from the RELEVANCE trial
A S Cottereau, L Rebaud, J Trotman, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 14, 2018
Progression-free survival at 24 months (PFS24) and subsequent outcome for patients with diffuse large B-cell lymphoma (DLBCL) enrolled on randomized clinical trials
M J Maurer, T M Habermann, Q Shi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 21, 2016
Prognostic value of baseline total metabolic tumor volume (TMTV0) measured on FDG-PET/CT in patients with peripheral T-cell lymphoma (PTCL)
A S Cottereau, S Becker, F Broussais, et al.
Leukemia
|
July 20, 2007
Long-term follow-up of high-dose treatment with autologous haematopoietic progenitor cell support in 693 patients with follicular lymphoma: an EBMT registry study
S Montoto, C Canals, A Z S Rohatiner, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 14, 2012
Phase III study of ACVBP versus ACVBP plus rituximab for patients with localized low-risk diffuse large B-cell lymphoma (LNH03-1B)
N Ketterer, B Coiffier, C Thieblemont, et al.
Leukemia
|
January 23, 2009
Recurrent genomic aberrations combined with deletions of various tumour suppressor genes may deregulate the G1/S transition in CD4+CD56+ haematodermic neoplasms and contribute to the aggressiveness of the disease
F Jardin, M Callanan, D Penther, et al.
Bone Marrow Transplantation
|
June 18, 2013
The outcome of reduced intensity allogeneic stem cell transplantation and autologous stem cell transplantation when performed as a first transplant strategy in relapsed follicular lymphoma: an analysis from the Lymphoma Working Party of the EBMT
S P Robinson, C Canals, J J Luang, et al.
Page
of 16